跳至主要内容
临床试验/KCT0003091
KCT0003091已完成未知

Comparison of Clinical Outcomes between Fractional Flow Reserve-guided Strategy and Angiography-guided Strategy in Treatment of Non-Infarction related Artery Stenosis in Patients with Acute Myocardial Infarction

Samsung Medical Center0 个研究点目标入组 562 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
562

研究概览

简要总结

In patients with acute MI and multivessel coronary artery disease, a strategy of selective PCI using FFR-guided decision making was superior to a strategy of routine PCI based on angiographic diameter stenosis for treatment of non-infarct related artery lesions regarding the risk of death, MI, or repeat revascularization.

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • ?Subject age 19 years or older
  • ?At least one of the following
  • 2-1. Acute ST-segment elevation myocardial infarction (STEMI)
  • ? STEMI : ST-segment elevation =0.1 mV in =2 contiguous leads or documented newly developed left bundle-branch block
  • 2-2. Acute non ST-segment elevation myocardial infarction (NSTEMI)
  • ? NSTEMI: NSTEMI is defined as a combination of criteria with mandated elevation of a cardiac biomarker, preferably high-sensitive cardiac troponin with at least one value above 99th percentile of the upper reference limit and at least one of the following:
  • 1)Symptoms of ischaemia.
  • 2)New or presumed new significant ST-T wave changes
  • 3)Development of pathological Q waves on ECG.
  • 4)Imaging evidence of new or presumed new loss of viable myocardium or regional wall motion abnormality.
  • 5)Intracoronary thrombus detected on angiography.
  • ?Primary percutaneous coronary intervention (PCI) in < 12 h after the onset of symptoms
  • ?Multivessel disease (at least one stenosis of >50% in a non-culprit vessel = 2.0 mm by visual estimation)
  • ?Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic evaluation and PCI and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.

排除标准

  • ?Severe stenosis with TIMI flow = II of the non-IRA artery
  • ?Unprotected left main coronary artery disease (stenosis > 50% by visual estimation)
  • ?Non-culprit stenosis not amenable for PCI treatment by operators decision)
  • ?Chronic total occlusion in non-infarct related artery
  • ? Cardiogenic shock (Killip class IV) already at presentation or the completion of culprit PCI
  • ?Intolerance to Aspirin, Clopidogrel, Plasugrel, Ticagrelor, Heparin, Bivaluridin, or Everolimus, Zotarolimus
  • ?Known true anaphylaxis to contrast medium (not allergic reaction but anaphylactic shock)
  • ?Pregnancy or breast feeding
  • ?Non-cardiac co-morbid conditions are present with life expectancy <1 year or that may result in protocol non-compliance (per site investigator’s medical judgment).
  • ?Other primary valvular disease with severe degree: severe mitral regurgitation or mitral stenosis, severe aortic regurgitation or aortic stenosis
  • ?Patients with a history of Coronary Artery Bypass Graft(CABG) or Treated with Fibrinolytic Therapy
  • ?Unwillingness or inability to comply with the procedures described in this protocol.

研究者

相似试验